Compare SGHT & SIEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SGHT | SIEB |
|---|---|---|
| Founded | 2011 | 1886 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 187.4M | 164.1M |
| IPO Year | 2021 | 1996 |
| Metric | SGHT | SIEB |
|---|---|---|
| Price | $3.88 | $1.80 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $9.08 | N/A |
| AVG Volume (30 Days) | ★ 235.0K | 25.2K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.16 | N/A |
| EPS | N/A | ★ 0.13 |
| Revenue | $77,363,000.00 | ★ $94,202,000.00 |
| Revenue This Year | $11.67 | N/A |
| Revenue Next Year | $10.39 | N/A |
| P/E Ratio | ★ N/A | $14.31 |
| Revenue Growth | N/A | ★ 12.28 |
| 52 Week Low | $2.40 | $1.68 |
| 52 Week High | $9.24 | $5.53 |
| Indicator | SGHT | SIEB |
|---|---|---|
| Relative Strength Index (RSI) | 48.49 | 50.73 |
| Support Level | $3.29 | $1.88 |
| Resistance Level | $4.29 | $2.23 |
| Average True Range (ATR) | 0.19 | 0.10 |
| MACD | 0.09 | 0.02 |
| Stochastic Oscillator | 69.80 | 73.97 |
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.
Siebert Financial Corp is a diversified financial services firm and provides a full range of brokerage and financial advisory services including securities brokerage, investment advisory and insurance offerings, and corporate stock plan administration solutions. The firm mainly provides online and traditional brokerage and related services to retail investors and also acts as an investment advisor for its subsidiary. The company operates in the securities brokerage and asset management industry. It also engages in Insurance services, Robo-advisory technology, and Prime brokerage business through its subsidiaries.